A Swedish study could not identify any specific microbiota profile in patients with IBS
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed to treat type 2 diabetes, but clinical evidence has shown its powerful effects on appetite suppression and weight reduction
This is why comparing one glass per week to daily heavy drinking as equivalent based on the word alcohol is scientifically inaccurate
Sepsis, being a life-threatening condition, is often associated with the risk of acute cardiac dysfunction
For patients in remote areas or those seeking telehealth convenience, PlexusDx serves all 50 states and uses licensed 503A compounding pharmacies to deliver medications directly, making safe deprescribing and optimization accessible without geographic barriers
Microdosing GLP-1 provides patients with treatment options that match their needs for flexible and personalized treatment initiation methods
